Suction Assisted Protein Lipectomy

Suction Assisted Protein Lipectomy (SAPL) for Advanced Lymphedema of the Arm or Leg

Patients whose lymphedema has progressed to the point that their limbs no longer adequately respond to conservative or lymphatic compression therapy may be candidates for Suction Assisted Protein Lipectomy (SAPL). This specialized procedure allows safe and dramatic reductions of large amounts of excess fat and protein present in chronic lymphedema. This allows us to achieve a consistent average overall reduction of excess volume of approximately 86% in legs and 111% in arms.

Suction Assisted Protein Lipectomy (SALP) Surgery Patient 1
Before Suction Assisted Protein Lipectomy (SAPL)
Suction Assisted Protein Lipectomy (SALP) Surgery Patient 1
After Suction Assisted Protein Lipectomy (SAPL)
Patient with a prior 17-year history of non-pitting lymphedema of the right arm, treated with SAPL.
After treatment, the affected right arm is now slightly smaller than the unaffected left side.

Patients who have lymphedema swelling in the arm or leg that is not fluid-predominant and has non-pitting edema may be good candidates. In many cases the affected extremity may feel soft, and a careful examination by a trained expert may be required to differentiate soft solid from soft fluid in an arm or leg.

Suction Assisted Protein Lipectomy (SALP) Surgery Patient 2
Before Suction Assisted Protein Lipectomy (SAPL)
Suction Assisted Protein Lipectomy (SALP) Surgery
After Suction Assisted Protein Lipectomy (SAPL)
34 year old patient with a 17-year history of congenital/spontaneous lymphedema of the left leg treated with SAPL. After treatment, the affected left leg is now smaller than the unaffected right leg.

The SAPL surgery has been proven to be safe and has consistent results both in our experience and in research published in multiple prominent medical journals. The lymphatics in the arm or leg are not damaged by the surgery. In fact, the reduction of excess fats and other solids improve the lymphatic drainage of the limb and considerably improve the management of the affected areas.

Massive obesity on its own has been shown to cause lymphedema, and multiple theories exist to explain the decreased lymphatic function in severely overweight arms and legs. Significantly overweight patients are not appropriate surgical candidates for lymphedema surgery. However, weight loss itself has been shown to improve such lymphedema.

It is critical to note that SAPL is different from cosmetic liposuction techniques, and this technique should not be performed by surgeons who are not specifically trained in this specialized type of procedure. A team approach with an experienced surgeon and trained lymphedema therapist is required.

Dr. Granzow has trained with Dr. Hakan Brorson in Sweden in this method of lymphedema treatment and has lectured with Dr. Brorson at the National Lymphedema Network (NLN) Annual Meeting.



Dr. Granzow in surgery with Dr. Hakan Brorson in Malmo, Sweden

SIGNIFICANT REDUCTIONS IN ARM OR LEG VOLUME

This specialized liposuction has been shown to be effective in reducing the size and firmness of the affected arm or leg for more than 20 years. Our results are consistent with those in the published literature.


Mean postoperative excess volume reduction in 95 women with arm lymphedema following breast cancer,
from Brorson, The Facts About Liposuction As A Treatment For Lymphoedema, Journal of Lymphoedema, 2008

The volume reductions achieved are permanent with continued compression following SAPL surgery. Dr. Granzow now offers additional surgeries, such as a Vascularized Lymph Node Transfer (VLNT) and/or Lymphaticovenous Anastomosis (LVA), at a later time to reduce the amount of compression needed to maintain the volume reduction. Dr. Granzow’s method of combing  lymphedema surgeries has shown excellent results. He was the first surgeon to successfully perform SAPL with subsequent VLNT and also LVA surgeries for the same patient to reduce the requirement for postoperative sleeve use.

Suction Assisted Protein Lipectomy (SALP) Surgery Patient 3
Patient Before Lymphedema Surgeries
Suction Assisted Protein Lipectomy (SALP) Surgery Patient 3
Patient After Lymphedema Surgeries
Patient 18 Months After Lymphatic Liposuction and 7 Months After Vascularized Lymph Node Transfer.
A volume reduction of over 80% was achieved and a compression garment is no longer worn during the day.

SAFETY OF SUCTION-ASSISTED PROTEIN LIPECTOMY

Dr. Granzow has found that the removal of pathologic lymphedema solids and fat with the SAPL procedure typically has improved the lymphatic drainage of an affected arm or leg.  Peer-reviewed papers in the medical literature have shown that SAPL has been shown to significantly decrease the incidence of surgical infections and cellulitis after surgery. Studies specifically looking at the lymphatic system before and after SAPL also have shown that SAPL does not appear to further damage the already damaged lymphatics in an arm or leg affected by lymphedema.